financetom
Business
financetom
/
Business
/
Atlassian Insider Sold Shares Worth $1,347,211, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlassian Insider Sold Shares Worth $1,347,211, According to a Recent SEC Filing
Sep 12, 2025 1:32 AM

04:06 AM EDT, 09/12/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Chief Executive Officer, Co-Founder, on September 10, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,347,211. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 107,310 Class A common shares of the company, with 107,310 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650372/000166612025000016/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Branded Footwear Retailer Genesco's Shares Are Tumbling Today
Why Branded Footwear Retailer Genesco's Shares Are Tumbling Today
Mar 8, 2024
Genesco Inc shares are plummeting after reporting fourth-quarter FY24 sales growth of 2% year-on-year to $738.95 million, beating the analyst consensus estimate of $705.66 million. Excluding the 14th week, sales would have decreased 2% for the fourth quarter of fiscal 2024. Total comparable sales declined 4%. Overall sales dropped 2% at Journeys, grew 6% at Schuh, up 9% at Johnston & Murphy,...
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing
Mar 8, 2024
08:09 AM EST, 03/08/2024 (MT Newswires) -- Muthusamy Shanmugam, Director, HEAD OF R&D, COO-NOVITIUM OPS, around March 05, 2024, sold 40,000 shares in Ani Pharmaceuticals ( ANIP ) for $2,630,864. Following the Form 4 filing with the SEC, Shanmugam has control over a total of 916,272 shares of the company, with 68,652 shares held directly and 847,620 shares controlled indirectly....
Regenxbio Insider Sold Shares Worth $365,220, According to a Recent SEC Filing
Regenxbio Insider Sold Shares Worth $365,220, According to a Recent SEC Filing
Mar 8, 2024
08:11 AM EST, 03/08/2024 (MT Newswires) -- Steve Pakola, Chief Medical Officer, on March 05, 2024, sold 12,878 shares in Regenxbio ( RGNX ) for $365,220. Following the Form 4 filing with the SEC, Pakola has control over a total of 107,192 shares of the company, with 107,192 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1590877/000156218024002430/xslF345X03/primarydocument.xml Price: 23.69, Change: +0.46, Percent Change:...
Shockwave Medical Insider Sold Shares Worth $507,294, According to a Recent SEC Filing
Shockwave Medical Insider Sold Shares Worth $507,294, According to a Recent SEC Filing
Mar 8, 2024
08:00 AM EST, 03/08/2024 (MT Newswires) -- Frank T Watkins, Director, on March 06, 2024, sold 2,000 shares in Shockwave Medical ( SWAV ) for $507,294. Following the Form 4 filing with the SEC, Watkins has control over a total of 4,532 shares of the company, with 4,532 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000075/xslF345X03/wk-form4_1709864771.xml Price: 261.95, Change: +5.84, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved